Cancer Drug Could Fight Scleroderma (HealthDay)
2nd Nov 2005, 16:31 GMT
The anti cancer-drug paclitaxel (Taxol) may also prevent skin thickening and small blood vessel destruction in people with scleroderma, according to a study that offers new clues into the causes of the debilitating disease.
Cancer Drug Could Fight Scleroderma (HealthDay) related news:
- Cancer Drug Could Fight Scleroderma (HealthDay) — Yahoo! News: Health News
- Paclitaxel may help treat scleroderma — News-Medical News Feed
- Protein Helps Vitamin E Fight Cancer (HealthDay) —
- New Technology Boosts Lung Cancer Treatment (HealthDay) — Yahoo! News: Health News
- Diabetes Raises Colon Cancer Risk (HealthDay) — Yahoo! News: Health News
- New clues into causes of scleroderma — KeralaNext: Latest News
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
- Researchers unveil reliable new approach to cancer drug delivery — Physics Org
- FDA grants orphan drug status to AstraZeneca cancer drug — Pharmaceutical Business Review Online
- New way to fight drug crime — BBC News | In Depth | Drugs | UK Edition
Latest news from UNTITLED FEED:
- Simple steps can speed heart attack care: study (Reuters)
- Hospitals want faster heart attack care (Associated Press)
- Diabetes threatens many of world's indigenous people (Reuters)
- Fast test catches heart blockages, U.S. study shows (Reuters)
- Children showing hardening of arteries -U.S. study (Reuters)
- Children showing hardening of arteries: U.S. study (Reuters)
- Two Canada professors win right to toke up at work (Reuters)
- Results mixed on Merck's new painkiller (Associated Press)
- Group gives advice on face transplants (Associated Press)
- Diabetes drug may cut heart risks: study (Reuters)